Structural discrimination in the COVID-19 vaccination programme for people with mental health and addiction issues: now is the time to be equally well.


Journal

The New Zealand medical journal
ISSN: 1175-8716
Titre abrégé: N Z Med J
Pays: New Zealand
ID NLM: 0401067

Informations de publication

Date de publication:
25 02 2022
Historique:
entrez: 21 6 2022
pubmed: 22 6 2022
medline: 24 6 2022
Statut: epublish

Résumé

People with mental health and substance use issues (tāngata whai ora katoa), regardless of ethnicity, are much more likely to be hospitalised or die from COVID-19 and were identified as a priority population (Priority Group 3) in Aotearoa New Zealand's vaccination roll-out plan. Data released by the Ministry of Health show that, despite tāngata whai ora katoa being a priority group, their vaccination rates are well below those of the general population. These inequities are pronounced for Māori with mental health and addiction issues (tāngata whai ora Māori). This is not acceptable. To support tāngata whai ora physical health and wellbeing, the onus is on all of us in the health system to actively reach out, have conversations, be supportive and provide accessible vaccination for people with mental health and addiction issues. Urgent action is needed. Now is the time to ensure tāngata whai ora katoa can be equally well.

Identifiants

pubmed: 35728158

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-139

Déclaration de conflit d'intérêts

The authors are part of Aotearoa Equally Well, an evidence-informed collaborative taking action across the health and health-related systems to achieve physical health equity for people who experience mental health and addiction issues.

Auteurs

Susanna Every-Palmer (S)

Head of Department, Department of Psychological Medicine, University of Otago, Wellington | Te Whare Wānanga o Otāgo ki Poneke, Wellington.

Ashley Koning (A)

Principal Advisor Addiction, Te Pou, Auckland.

Linda Smith (L)

Consumer Advisor, Canterbury District Health Board | Te Poari Hauora ō Waitaha, Christchurch.

Ruth Cunningham (R)

Senior Research Fellow, Director EleMent Research Group, Department of Public Health, University of Otago, Wellington | Te Whare Wānanga o Otāgo ki Poneke, Wellington.

Cameron Lacey (C)

Senior Lecturer, Māori Indigenous Health Institute (MIHI), University of Otago, Christchurch |Te Whare Wānanga o Otāgo ki Ōtautahi, Christchurch.

Deborah Peterson (D)

Senior Research Fellow Department of Public Health, University of Otago, Wellington | Te Whare Wānanga o Otāgo ki Poneke, Wellington.

Angela Jury (A)

Research Manager, Te Pou, Auckland.

Kate M Scott (KM)

Head of Department, Department of Psychological Medicine, University of Otago | Te Whare Wānanga o Otāgo, Dunedin.

Tony Dowell (T)

Professor of Primary Health Care and General Practice, University of Otago, Wellington | Te Whare Wānanga o Otāgo ki Poneke, Wellington.

Helen Lockett (H)

Strategic Policy Advisor, the Wise Group, Hamilton; Honorary Senior Research Fellow, Department of Public Health, University of Otago, Wellington | Te Whare Wānanga o Otāgo ki Poneke, Wellington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH